Minerva Biolabs

Minerva Biolabs is a specialized provider of contamination control products and services, serving the global life sciences market from its base in Cologne, Germany. The company's core expertise lies in the detection and elimination of mycoplasma and other contaminants in cell cultures, complemented by a growing portfolio for nucleic acid extraction, PCR consumables, and lab cleaning. It operates a hybrid business model, selling proprietary kits and reagents while also offering contract manufacturing services. With a focus on compliance with international pharmacopeial standards (EP, USP, JP), Minerva targets academic, pharmaceutical, and biotech customers who require high-quality, reliable contamination management.

Molecular biology-based detection (qPCR, RT-PCR, dPCR) and biochemical elimination technologies for laboratory contaminants including mycoplasma, bacteria, and nucleic acids.

Minerva competes with large, diversified life science tools companies (e.g., Lonza, Merck KGaA, Thermo Fisher) that offer broad portfolios, and with smaller niche players in contamination control. Its differentiation lies in deep specialization, regulatory expertise, and a comprehensive, integrated product suite for contamination management.